Curative Biosciences (Curative Biosciences) Liabilities-to-Assets : 51.43 (As of Mar. 2018)

Curative Biosciences Liabilities-to-Assets Chart

Curative Biosciences Annual Data
	Trend	Jun08	Jun09	Jun10	Jun11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun17
Liabilities-to-Assets		Get a 7-Day Free Trial					5.64	23.81	70.60	124.00	316.50

Curative Biosciences Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18
Liabilities-to-Assets	Get a 7-Day Free Trial															205.33	316.50	324.50	675.00	51.43

Competitive Comparison of Curative Biosciences's Liabilities-to-Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Curative Biosciences's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curative Biosciences's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curative Biosciences's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Curative Biosciences's Liabilities-to-Assets falls into.

Curative Biosciences Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Curative Biosciences's Liabilities-to-Assets Ratio for the fiscal year that ended in Jun. 2017 is calculated as:

Curative Biosciences's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biosciences  (OTCPK:CBDX) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Curative Biosciences Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Curative Biosciences's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Curative Biosciences (Curative Biosciences) Business Description